112 related articles for article (PubMed ID: 25841669)
1. Molecular modeling, simulation and virtual screening of MurD ligase protein from Salmonella typhimurium LT2.
Samal HB; Das JK; Mahapatra RK; Suar M
J Pharmacol Toxicol Methods; 2015; 73():34-41. PubMed ID: 25841669
[TBL] [Abstract][Full Text] [Related]
2. Identification of promising molecules against MurD ligase from Acinetobacter baumannii: insights from comparative protein modelling, virtual screening, molecular dynamics simulations and MM/PBSA analysis.
Jha RK; Khan RJ; Amera GM; Singh E; Pathak A; Jain M; Muthukumaran J; Singh AK
J Mol Model; 2020 Oct; 26(11):304. PubMed ID: 33068184
[TBL] [Abstract][Full Text] [Related]
3. Inhibitor design strategy based on an enzyme structural flexibility: a case of bacterial MurD ligase.
Perdih A; Hrast M; Barreteau H; Gobec S; Wolber G; Solmajer T
J Chem Inf Model; 2014 May; 54(5):1451-66. PubMed ID: 24724969
[TBL] [Abstract][Full Text] [Related]
4. Comparative genomics study of Salmonella Typhimurium LT2 for the identification of putative therapeutic candidates.
Samal HB; Prava J; Suar M; Mahapatra RK
J Theor Biol; 2015 Mar; 369():67-79. PubMed ID: 25637765
[TBL] [Abstract][Full Text] [Related]
5. Homology modeling, molecular dynamics and inhibitor binding study on MurD ligase of Mycobacterium tuberculosis.
Arvind A; Kumar V; Saravanan P; Mohan CG
Interdiscip Sci; 2012 Sep; 4(3):223-38. PubMed ID: 23292696
[TBL] [Abstract][Full Text] [Related]
6. Benzene-1,3-dicarboxylic acid 2,5-dimethylpyrrole derivatives as multiple inhibitors of bacterial Mur ligases (MurC-MurF).
Perdih A; Hrast M; Barreteau H; Gobec S; Wolber G; Solmajer T
Bioorg Med Chem; 2014 Aug; 22(15):4124-34. PubMed ID: 24953950
[TBL] [Abstract][Full Text] [Related]
7. Discovery of new inhibitors of the bacterial peptidoglycan biosynthesis enzymes MurD and MurF by structure-based virtual screening.
Turk S; Kovac A; Boniface A; Bostock JM; Chopra I; Blanot D; Gobec S
Bioorg Med Chem; 2009 Mar; 17(5):1884-9. PubMed ID: 19223185
[TBL] [Abstract][Full Text] [Related]
8. Combining molecular docking and molecular dynamics studies for modelling Staphylococcus aureus MurD inhibitory activity.
Azam MA; Jupudi S; Saha N; Paul RK
SAR QSAR Environ Res; 2019 Jan; 30(1):1-20. PubMed ID: 30406684
[TBL] [Abstract][Full Text] [Related]
9. MurD enzymes: some recent developments.
Šink R; Barreteau H; Patin D; Mengin-Lecreulx D; Gobec S; Blanot D
Biomol Concepts; 2013 Dec; 4(6):539-56. PubMed ID: 25436755
[TBL] [Abstract][Full Text] [Related]
10. Identification of a Potential Inhibitor Targeting MurC Ligase of the Drug Resistant Pseudomonas aeruginosa Strain through Structure-Based Virtual Screening Approach and In Vitro Assay.
Messaoudi A; Zoghlami M; Basharat Z; Sadfi-Zouaoui N
Curr Pharm Biotechnol; 2019; 20(14):1203-1212. PubMed ID: 31333120
[TBL] [Abstract][Full Text] [Related]
11. A novel 2-oxoindolinylidene inhibitor of bacterial MurD ligase: Enzyme kinetics, protein-inhibitor binding by NMR and a molecular dynamics study.
Simčič M; Pureber K; Kristan K; Urleb U; Kocjan D; Grdadolnik SG
Eur J Med Chem; 2014 Aug; 83():92-101. PubMed ID: 24952377
[TBL] [Abstract][Full Text] [Related]
12. Identification of Potential Inhibitors of MurD Enzyme of
Zheng X; Zheng T; Liao Y; Luo L
Molecules; 2021 Oct; 26(21):. PubMed ID: 34770835
[No Abstract] [Full Text] [Related]
13. MurD enzymes from different bacteria: evaluation of inhibitors.
Barreteau H; Sosič I; Turk S; Humljan J; Tomašić T; Zidar N; Hervé M; Boniface A; Peterlin-Mašič L; Kikelj D; Mengin-Lecreulx D; Gobec S; Blanot D
Biochem Pharmacol; 2012 Sep; 84(5):625-32. PubMed ID: 22705647
[TBL] [Abstract][Full Text] [Related]
14. Novel naphthalene-N-sulfonyl-D-glutamic acid derivatives as inhibitors of MurD, a key peptidoglycan biosynthesis enzyme.
Humljan J; Kotnik M; Contreras-Martel C; Blanot D; Urleb U; Dessen A; Solmajer T; Gobec S
J Med Chem; 2008 Dec; 51(23):7486-94. PubMed ID: 19007109
[TBL] [Abstract][Full Text] [Related]
15. Discovery of novel benzene 1,3-dicarboxylic acid inhibitors of bacterial MurD and MurE ligases by structure-based virtual screening approach.
Perdih A; Kovac A; Wolber G; Blanot D; Gobec S; Solmajer T
Bioorg Med Chem Lett; 2009 May; 19(10):2668-73. PubMed ID: 19369074
[TBL] [Abstract][Full Text] [Related]
16. Extra precision docking, free energy calculation and molecular dynamics studies on glutamic acid derivatives as MurD inhibitors.
Azam MA; Jupudi S
Comput Biol Chem; 2017 Aug; 69():55-63. PubMed ID: 28575732
[TBL] [Abstract][Full Text] [Related]
17. Homology modeling and molecular dynamic simulation of UDP-N-acetylmuramoyl-l-alanine-d-glutamate ligase (MurD) from Mycobacterium tuberculosis H37Rv using in silico approach.
Isa MA
Comput Biol Chem; 2019 Feb; 78():116-126. PubMed ID: 30504089
[TBL] [Abstract][Full Text] [Related]
18. In silico approach towards identification of potential inhibitors of Helicobacter pylori DapE.
Mandal RS; Das S
J Biomol Struct Dyn; 2015; 33(7):1460-73. PubMed ID: 25204745
[TBL] [Abstract][Full Text] [Related]
19. Phosphinate inhibitors of UDP-N-acetylmuramoyl-L-alanyl-D-glutamate: L-lysine ligase (MurE).
Strancar K; Boniface A; Blanot D; Gobec S
Arch Pharm (Weinheim); 2007 Mar; 340(3):127-34. PubMed ID: 17335103
[TBL] [Abstract][Full Text] [Related]
20. New 5-benzylidenethiazolidin-4-one inhibitors of bacterial MurD ligase: design, synthesis, crystal structures, and biological evaluation.
Zidar N; Tomašić T; Šink R; Kovač A; Patin D; Blanot D; Contreras-Martel C; Dessen A; Premru MM; Zega A; Gobec S; Mašič LP; Kikelj D
Eur J Med Chem; 2011 Nov; 46(11):5512-23. PubMed ID: 21963114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
